AN7602-d4 (Crisaborole Metabolite)

AN7602-d4 is a metabolite of Crisaborole, which is a medication used in the treatment of atopic dermatitis or eczema. Atopic dermatitis is a chronic skin condition characterized by inflammation and itching. Crisaborole works by reducing inflammation and stopping the immune system from overreacting, which is a common occurrence in people with eczema. AN7602-d4 is an important compound in the study of Crisaborole's metabolism and pharmacokinetics. It is used as a reference standard in analytical chemistry and pharmacological studies. The chemical formula of AN7602-d4 is C14H6D4NO3, and its molecular weight is 239.27 g/mol. AN7602-d4 is a deuterated version of AN7602, which is a primary metabolite of Crisaborole. The deuterated form is used to distinguish between the parent compound and the metabolite during pharmacokinetic studies. The compound is administered orally, and its absorption, distribution, metabolism, and excretion are studied to determine the effectiveness and safety of Crisaborole. AN7602-d4 is a valuable tool for understanding the mechanism of action and pharmacokinetics of Crisaborole. It is used in preclinical and clinical studies to evaluate the efficacy and safety of the drug in patients with atopic dermatitis. The compound is also used in the development of new drugs and therapies for skin diseases.